---
schema_version: "secwatch.filing_event.v1"
accession: "0000785161-24-000015"
form_type: "8-K"
ticker: "EHC"
cik: "0000785161"
company_name: "Encompass Health Corp"
filed_at: "2024-03-11T23:59:59+00:00"
generated_at: "2026-06-05T00:14:53.950944+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Encompass Health reiterates FY2024 guidance at Barclays conference; no changes

## Summary
- Company to present at Barclays Global Healthcare Conference on March 12, 2024, with CEO and CFO.
- Reaffirms FY2024 guidance: net operating revenue $5,200M-$5,300M.
- Adjusted EBITDA reaffirmed at $1,015M-$1,055M; adjusted EPS $3.77-$4.06.
- Guidance unchanged from Feb 7 8-K and Feb 8 earnings call.
- No new financial or operational updates disclosed.

## SEC filing metadata
- accession: 0000785161-24-000015
- form_type: 8-K
- ticker: EHC
- cik: 0000785161
- company_name: Encompass Health Corp
- filed_at: 2024-03-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/785161/000078516124000015/0000785161-24-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/785161/000078516124000015/ehc-20240311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000785161-24-000015
- JSON: https://secwatch.observer/filing/0000785161-24-000015.json
- Plain text: https://secwatch.observer/filing/0000785161-24-000015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.